0000899243-18-000596.txt : 20180105
0000899243-18-000596.hdr.sgml : 20180105
20180105170212
ACCESSION NUMBER: 0000899243-18-000596
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180103
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daniel Thomas O
CENTRAL INDEX KEY: 0001538894
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 18514072
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZAFGEN, INC.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
BUSINESS PHONE: 617-622-4003
MAIL ADDRESS:
STREET 1: 175 PORTLAND STREET
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02114
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-03
0
0001374690
ZAFGEN, INC.
ZFGN
0001538894
Daniel Thomas O
C/O ZAFGEN, INC.,
175 PORTLAND STREET, 4TH FLOOR
BOSTON
MA
02114
1
0
0
0
Common Stock
2018-01-03
4
A
0
8687
5.18
A
19452
D
The common stock was issued in lieu of cash fees under the Non-Employee Director Compensation Policy pursuant to a Restricted Stock Agreement and the restrictions lapse over a period of one year starting January 1, 2018 on quarterly basis in arrears.
/s/ Laurie Burlingame (Attorney-In-Fact)
2018-01-05